perioperative management of glp 1 agonists Use GLP-1 Receptor in Patients Undergoing Cardiac Procedures: A Scoping Review GLP-1 Receptor Agonists And Aspiration
Description
95% CI: 7.89 to 2.51
Chicago Kumar Malesu, Vijay
Duration : The program runs from July 1, 2026 through December 31, 2027, after which the BALANCE Model is scheduled to begin
January 2026 saw the launch of Wegovy pill in the US, the first oral GLP-1 approved for obesity
(4) Urbina, J., et al
Or Ozempic, because its getting so much hype
